Business
Edgewell Personal Care markets shaving, sun-care, skin-care and feminine-care products.
Edgewell Personal Care contracted revenue, remained profitable, generated positive free cash flow at a 4.3% operating margin. Margins were thin and capital spending and inventory grew faster than revenue.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 1.3%Watch
- Profitability — Net income declined 74.2% to $25.4M from $98.6MWatch
- Cash flow — Free cash flow turned positive at $41.4M from an outflow of $287.5MOK
- Margins — Operating margin contracted 450 bps to 4.34%Watch
- Accounting — Margins were thin and capital spending and inventory grew faster than revenueNote
- Insiders — 0 purchases and 1 salesNote
Where the revenue comes from
Fiscal 2025, as EDGEWELL PERSONAL CARE Co reports it. History and quarterly detail are in the app.
- Wet Shave$1.2B
- Sun and Skin Care$743.1M
- Feminine Care$261.5M
Leadership changes
From EDGEWELL PERSONAL CARE Co's own filings, the day they're filed.
- Paul R. Hibbert · departureeff. 2026-06-01
- Daniel J. Sullivan · Chief Operating Officer · departureeff. 2025-10-01
- Francesca Weissman · principal financial officer · appointmenteff. 2024-12-01
Latest filings
- 8-K · Company announcement2026-08-05
- 10-Q · Quarterly report2026-08-05
- 8-K · Company announcement2026-05-26
- 10-Q · Quarterly report2026-05-06
- 8-K · Company announcement2026-05-06
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about EDGEWELL PERSONAL CARE Co, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.